ATH
Click for more information
0.00% 0.3¢ alterity therapeutics limited

Ann: Approval of PBT2 Orphan Designation for Huntingtons Disease, page-13

  1. Cowanna
    82 Posts.
    lightbulb Created with Sketch. 4
    clock Created with Sketch.
    01/06/15
    12:36
    Post #: 15389036
    itm
    thank you for that info, approval from the EMA could have a positive influence on approvals being granted from other countries. Maybe Dr Smith would be re engaged to further develop marketing in European
    countries.
    PBT Price at posting: 20.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Bitcoin: Current State of Play & Where to Next | Swyftx
right-arrow Created with Sketch.
QBE QBE records share price plunge despite doubling profits in the first half of 2024
right-arrow Created with Sketch.
RLT South Africa-based Renergen brings liquid helium facility online
right-arrow Created with Sketch.
TG6 TG Metals reports high grade lithium hits approaching 3% at Jaegermeister
right-arrow Created with Sketch.
NEWS Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market
right-arrow Created with Sketch.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
right-arrow Created with Sketch.
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.3¢ 		Change
0.000(0.00%) 		Mkt cap ! $15.96M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $33 11K

Buyers (Bids)

No. Vol. Price($)
38 46614064 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 126748541 18
View Market Depth
Last trade - 10.00am 12/08/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.